EH
IBRX icon

Equitable Holdings’s ImmunityBio IBRX Stock Holding History

Equitable Holdings’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Buy
15,620
+120
+0.8% +$908 ﹤0.01% 1744
2026
Q1 		$30.7K Sell
15,500
-425
-3% -$2.91K ﹤0.01% 1676
2025
Q4 		$31.5K Buy
15,925
+425
+3% +$963 ﹤0.01% 1568
2025
Q3 		$38.1K Buy
15,500
+1,000
+7% +$2.58K ﹤0.01% 1514
2025
Q2 		$38.3K Buy
+14,500
New +$39K ﹤0.01% 1439

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Equitable Holdings's IBRX Position: Q2 2026 in Review

Equitable Holdings increased its ImmunityBio (IBRX) stake by 0.77% in Q2 2026, buying an estimated $908 and bringing the position to 15,620 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Equitable Holdings first reported a position in IBRX in Q2 2025 and has held it in 5 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Equitable Holdings held 15,620 shares of ImmunityBio worth $137K as of Q2 2026.
  • Equitable Holdings bought 120 ImmunityBio shares in Q2 2026, an estimated $908.
  • ImmunityBio made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1744 holding.
  • Equitable Holdings first reported a position in ImmunityBio in Q2 2025 and has held it in 5 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.